CD274 and lung carcinoma: The PI3K-Akt, MAPK, and NF-kappa B signaling pathways and AP-1 are involved in the upregulation of PD-L1 induced by different EGFR-TKI resistance mechanisms that promote immune escape in lung cancer [26].